–
Enanta Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−110
FY22:
−124
FY23:
−137
FY24:
−122
FY25:
−85.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−104
FY22:
−119
FY23:
−123
FY24:
−105
FY25:
−71.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−108
FY22:
−122
FY23:
−131
FY24:
−118
FY25:
−83.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.0
FY22:
−122
FY23:
−134
FY24:
−116
FY25:
−81.9
All amounts in millions USD